Publications
- Potential of anti-Candida antibodies in immunoprophylaxis Immunotherapy, 2010; 2, 171 - 183
- Serum (1-3) ß-D-glucan as a noninvasive adjunct marker for the diagnosis and follow up of Pneumocystis jiroveci pneumonia (PJP) in patients with HIV infection. Clinical Infectious Diseases, 2009; 10
- Kinetic patterns of Candida albicans germ tube antibody (CAGTA) in critically ill patients: influence on mortality Clinical Vaccine Immunology, 2009; 16, 1527 - 1528
- Serum (1-3)-ß-D glucan assay for the diagnosis of Pneumocystis jiroveci pneumonia Clinical Vaccine Immunology, 2010; 17, 202 - 203
- Serum (1-3) ß-D-glucan as a noninvasive adjunct marker for the diagnosis and follow up of Pneumocystis jiroveci pneumonia in patients with HIV infection Clinical Infectious Diseases, 2010; 50, 451 - 452
- The impact of oral contraceptive usage on women's periodontal health and the subgingival occurrence of aggressive periodontopathogens and Candida species Journal of Periodontology, 2010; 81, 1010 - 1018
- Diagnostic utility of (1-3)-ß-D glucan and galactomannan antigenemia in adult liver transplant recipients in the Intensive Care Unit Journal of Clinical Microbiology, 2010
- What makes Aspergillus fumigatus a successful pathogen?. Genes and molecules involved in invasive aspergillosis Rev Iberoam Micol. 2010, 2010; 27
- Grupo de Estudio de Micología Médica de la SEIMC (GEMICOMED). [Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 update] Enferm Infecc Microbiol Clin. 2011 Jan;29(1):39.e1-15. doi 10.1016/j.eimc.2010.08.005, 2010; 29(1):39.e1-15
- Prevalence of Candida species in necrotic pulp with chronic periapical processes Acta Odontol Latinoam. 2011;24:183-7, 2011
—
10 Items per Page